Pharma lobbying group lets in generic rival

Published



A major pharmaceutical trade group is adding a generic drugmaker to its ranks, a move that may rankle traditional drug giants.

The Pharmaceutical Research and Manufacturers of America announced Friday that Teva Pharmaceuticals would join the group. Teva is primarily a generic drug maker that produces copies of brand-name products, making Teva a rival to the association’s members that produce brand-name drugs.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.